Based on the GME prediction the Global Pharmaceutical Membrane Filtration Market will expand with a CAGR value of 12.50 percent from 2021 to 2026. Membrane Filtration is vastly incorporated in chemical procedures and the fields of biotechnology and pharmaceuticals. It has proved to be a valuable method for cleaning and filtering industrial procedure liquid and waste liquid.The rapid growth in the biopharmaceutical and pharmaceutical industries, increasing adoption of single-use technologies, developments in the drug production process with a wide range of usage of membrane filtration techniques in the pharmaceutical industry.
Browse 159 Market Data Tables and 119 Figures
spread through 189 Pages and in-depth TOC on "Pharmaceutical Membrane Filtration Market - Forecast to 2026"
By Product
(Filters, Systems, Accessories), By
Technique (Microfiltration, Ultrafiltration, Nanofiltration, Reverse Osmosis,
Ion Exchange), By Material (PES, PVDF, Nylon, PTFE, MCE & CA, PCTE, Other
Materials [polypropylene, regenerated cellulose, gelatin, and PVC]), By
Application (Final Product Processing [API Filtration, Sterile Filtration,
Protein Purification, Vaccine and Antibody Processing, Formulation and Filling
Solutions, Viral Clearance], Raw Material Filtration [Media Buffers,
Prefiltration, Bioburden Reduction], Cell Separation, Water Purification), By
Region (North America, Asia Pacific, CSA, Europe, and the Middle East and
Africa); End-User Landscape, Company Market Share Analysis & Competitor
Analysis
·
The leading segment in the estimated timeframe will
be raw material filtration
·
The Asia Pacific region will dominant the global
market n in terms of revenue and share. This is attributed to the significant
increase in pharma spending by APAC countries
·
In July 2018, Pall Corporation allied with the BioSciencesCorp,
intending to boost the manufacturing process
·
Repligen Corporation (US), Danaher (US),
Graver Technologies (US), Merck Millipore (Germany), Sartorius Stedim Biotech
(France), Thermo Fisher Scientific (US), GEA Group (Germany), Koch Membrane
Systems (US), 3M Company (US), Porvair Plc are the key companies.
Browse the Report @ https://www.globalmarketestimates.com/market-report/global-pharmaceutical-membrane-filtration-market-2781
Product Outlook (Revenue, USD Billion,
2021-2026)
·
Filters
·
Systems
·
Accessories
Technique Outlook (Revenue, USD Billion,
2021-2026)
·
Microfiltration
·
Ultrafiltration
·
Nanofiltration
·
Reverse Osmosis
·
Ion Exchange
Material Outlook (Revenue, USD Billion,
2021-2026)
·
PES
·
PVDF
·
Nylon
·
PTFE
·
MCE & CA
·
PCTE
·
Other Materials (polypropylene, regenerated
cellulose, gelatin, and PVC)
Application Outlook (Revenue, USD Billion,
2021-2026)
·
Final Product Processing
·
API Filtration
·
Sterile Filtration
·
Protein Purification
·
Vaccine and Antibody Processing
·
Formulation and Filling Solutions
·
Viral Clearance
·
Raw Material Filtration
·
Media Buffers
·
Prefiltration
·
Bioburden Reduction
·
Cell Separation
·
Water Purification
Regional Outlook
(Revenue, USD Billion, 2021-2026)
North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of APAC
Central & South
America
- Brazil
- Argentina
- Rest of CSA
Middle
East & Africa
- Saudi Arabia
- UAE
- Rest of MEA
Contact:
Tracy Simon
Email address: tracy.simon@globalmarketestimates.com
Phone
Number: +16026667238
Website:
https://www.globalmarketestimates.com/
No comments:
Post a Comment